fda compounding semaglutide enforcement november 2025 Warns on Certain Forms of Compounded glp-1 compounding news november 2025

proposed a novel pathway for renal anemia based on an in vitro test evaluating the cytotoxic effect of uremic plasma on healthy RBCs and CD14 ++ /CD16 + monocytes

This provides a biological basis for considering whether pharmacological GLP-1 therapies, which achieve much higher systemic levels, could also reach the joint and potentially have local effects. Additionally, scientists found that the level of GLP-1 hormone in the synovial fluid is directly tied to the levels in the blood of arthritis patients

10.1212/wnl.25.7.603 24 CarricoC.MeyerJ

On the other hand, Liraglutide, which requires daily injections, may be more suited to patients who need more immediate effects due to its shorter half-life but are comfortable with daily injections